Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage

Infection and Immunity

Volumn 72, Issue 10, 2004, Pages 6112-6124

  Cook, Rosemary M ^a   Carvalho Queiroz, Claudia ^a   Wilding, Gregory ^b   LoVerde, Philip T ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYTOKINE; DNA VACCINE; FILAMIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; NUCLEIC ACID; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PURIFICATION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLEEN CELL; T LYMPHOCYTE; VACCINE PRODUCTION;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIOXIDANTS; CELL DIVISION; CONTRACTILE PROTEINS; CYTOKINES; CYTOPLASM; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; LIFE CYCLE STAGES; MICE; MICE, INBRED BALB C; MICROFILAMENT PROTEINS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SPLEEN; SUPEROXIDE DISMUTASE; T-LYMPHOCYTES; VACCINATION; VACCINES, DNA;

EID: 4644286484     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.10.6112-6124.2004     Document Type: Article

References (57)

1. Agnew, A. M., H. M. Murare, and M. J. Doenhoff. 1993. Immune attrition of adult schistosomes. Parasite Immunol. 15:261-271.
2. Ahmed, S. F., I. P. Oswald, P. Caspar, S. Hieny, L. Keefer, A. Sher, and S. L. James. 1997. Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni. Infect. Immun. 65:219-226.
3. Bagwell, C. B., and E. G. Adams. 1993. Fluorescence spectral overlap compensation for any number of flow cytometry parameters. Ann. N. Y. Acad. Sci. 677:167-184.
4. Bergquist, N. R. 1995. Controlling schistosomiasis by vaccination: a realistic option? Parasitol. Today 11:191-194.
5. Bergquist, N. R. 1998. Schistosomiasis vaccine development: progress and prospects. Mem. Inst. Oswaldo Cruz. 93(Suppl. 1):95-101.
6. Bergquist, N. R., and D. G. Colley. 1998. Schistosomiasis vaccines: research to development. Parasitol. Today 14:99-104.
7. Bergquist, R., M. Al-Sherbiny, R. Barakat, and R. Olds. 2002. Blueprint for schistosomiasis vaccine development. Acta Trop. 82:183-192.
8. Biral, D., L. Dalla Libera, C. Franceschi, and A. Margreth. 1979. Microplate enzyme-linked immunosorbent assay in the study of the structural relationship between myosin light chains. J. Immunol. Methods 31:93-100.
9. Brophy, P. M., and D. I. Pritchard. 1992. Immunity to helminths: ready to tip the biochemical balance? Parasitol. Today 8:419-422.
10. Butterworth, A. E. 1984. Cell-mediated damage to helminths. Adv. Parasitol. 23:143-235.
11. Butterworth, A. E., D. W. Dunne, A. J. Fulford, K. J. Thorne, K. Gachuhi, J. H. Ouma, and R. F. Sturrock. 1992. Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control. Immunol. Investig. 21:391-407.
12. Callahan, H. L. C., R. K. Crouch, and E. R. James. 1988. Helminth antioxidant enzymes: a protective mechanism against host oxidants? Parasitol. Today 4:218-225.
13. Capron, A., J. P. Dessaint, M. Capron, J. H. Ouma, and A. E. Butterworth. 1987. Immunity to schistosomes: progress toward vaccine. Science 238:1065-1072.
14. Capron, M. C. A. 1994. Immunoglobulin E and effector cells in schistosomiasis. Science 264:1876-1877.
15. Carvalho-Queiroz, C., R. Cook, C. C. Wang, R. Correa-Oliveira, N. A. Bailey, N. K. Egilmez, E. Mathiowitz, and P. T. LoVerde. 2004. Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes. Infect. Immun. 72:2635-2647.
16. Chlichlia, K., M. Bahgat, A. Ruppel, and V. Schirrmacher. 2001. DNA vaccination with asparaginyl endopeptidase (Sm32) from the parasite Schistosoma mansoni: anti-fecundity effect induced in mice. Vaccine 20:439-447.
17. Cioli, D. 1976. Transfer of Schistosoma mansoni into the mesenteric veins of hamsters. Int. J. Parasitol. 6:349-354.
18. Colley, D. G., J. A. Cook, G. L. Freeman, Jr., R. K. Bartholomew, and P. Jordan. 1977. Immune responses during human schistosomiasis mansoni. I. In vitro lymphocyte blastogenic responses to heterogeneous antigenic preparations from schistosome eggs, worms and cercariae. Int. Arch. Allergy Appl. Immunol. 53:420-433.
19. Da'dara, A. A., P. J. Skelly, M. M. Wang, and D. A. Harn. 2001. Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 20:359-369.
20. Dean, D. A., B. L. Mangold, J. R. Georgi, and R. H. Jacobson. 1984. Comparison of Schistosoma mansoni migration patterns in normal and irradiated cercaria-immunized mice by means of autoradiographic analysis. Evidence that worm elimination occurs after the skin phase in immunized mice. Am. J. Trop. Med. Hyg. 33:89-96.
21. Dupre, L., O. Poulain-Godefroy, E. Ban, N. Ivanoff, M. Mekranfar, A. M. Schacht, A. Capron, and G. Riveau. 1997. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase. Parasite Immunol. 19:505-513.
22. Duvall, R. H., and W. B. DeWitt. 1967. An improved perfusion technique for recovering adult schistosomes from laboratory animals. Am. J. Trop. Med. Hyg. 16:483-486.
23. Engels, D., L. Chitsulo, A. Montresor, and L. Savioli. 2002. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop. 82:139-146.
24. Fallon, P. G., P. Smith, and D. W. Dunne. 1998. Type 1 and type 2 cytokine-producing mouse CD4+ and CD8+ T cells in acute Schistosoma mansoni infection. Eur. J. Immunol. 28:1408-1416.
25. Gazzinelli, R. T., I. P. Oswald, S. L. James, and A. Sher. 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 148:1792-1796.
26. Helmby, H., M. Kullberg, and M. Troye-Blomberg. 1998. Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect. Immun. 66:5167-5174.
27. Hoffmann, K. F., S. L. James, A. W. Cheever, and T. A. Wynn. 1999. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J. Immunol. 163:927-938.
28. Hong, Z., D. J. Kosman, A. Thakur, D. Rekosh, and P. T. LoVerde. 1992. Identification and purification of a second form of Cu/Zn superoxide dismutase from Schistosoma mansoni. Infect. Immun. 60:3641-3651.
29. Kellar, K. L., R. R. Kalwar, K. A. Dubois, D. Crouse, W. D. Chafin, and B. E. Kane. 2001. Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry 45:27-36.
30. LoVerde, P. T. 1998. Do antioxidants play a role in schistosome host-parasite interactions? Parasitol. Today 14:109-113.
31. +-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect. Immun. 70:812-819.
32. + T and B cells during murine Schistosoma mansoni infection. Infect. Immun. 69:271-280.
33. Maizels, R. M., D. A. Bundy, M. E. Selkirk, D. F. Smith, and R. M. Anderson. 1993. Immunological modulation and evasion by helminth parasites in human populations. Nature 365:797-805.
34. Mei, H., and P. T. LoVerde. 1995. Schistosoma mansoni: cloning the gene encoding glutathione peroxidase. Exp. Parasitol. 80:319-322.
35. Mei, H., and P. T. LoVerde. 1997. Schistosoma mansoni: the developmental regulation and immunolocalization of antioxidant enzymes. Exp. Parasitol. 86:69-78.
36. Mei, H. T., A. Schwartz, and J. P. LoVerde. 1996. Expression and characterization of glutathione peroxidase activity in the human blood fluke Schistosoma mansoni. Infect. Immun. 64:4299-4306.
37. Mkoji, G. M., J. M. Smith, and R. K. Prichard. 1988. Antioxidant systems in Schistosoma mansoni: correlation between susceptibility to oxidant killing and the levels of scavengers of hydrogen peroxide and oxygen free radicals. Int. J. Parasitol. 18:661-666.
38. Nare, B., J. M. Smith, and R. K. Prichard. 1990. Schistosoma mansoni: levels of antioxidants and resistance to oxidants increase during development. Exp. Parasitol. 70:389-397.
39. Oswald, I. P., R. T. Gazzinelli, A. Sher, and S. L. James. 1992. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. J. Immunol. 148:3578-3582.
40. Oswald, I. P., T. A. Wynn, A. Sher, and S. L. James. 1992. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc. Natl. Acad. Sci. USA 89:8676-8680.
41. Pardoll, D. M., and A. M. Beckerleg. 1995. Exposing the immunology of naked DNA vaccines. Immunity 3:165-169.
42. Pearce, E. J., and S. L. James. 1986. Post lung-stage schistosomula of Schistosoma mansoni exhibit transient susceptibility to macrophage-mediated cytotoxicity in vitro that may relate to late phase killing in vivo. Parasite Immunol. 8:513-527.
43. Pearce, E. J., and A. S. MacDonald. 2002. The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2:499-511.
44. Pearce, E. J., and A. Sher. 1987. Mechanisms of immune evasion in schistosomiasis. Contrib. Microbiol. Immunol. 8:219-232.
45. Pedras-Vasconcelos, J. A., and E. J. Pearce. 1996. Type 1 CD8+ T cell responses during infection with the helminth Schistosoma mansoni. J. Immunol. 157:3046-3053.
46. Robinson, H. L. 1997. Nucleic acid vaccines: an overview. Vaccine 15:785-787.
47. Sambrook, F., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
48. Schirmacher, V., P. Forg, W. Dalemans, K. Chlichlia, Y. Zeng, P. Fournier, and P. von Hoegen. 2000. Intra-pinna anti-tumor vaccination with self-replicating infectious RNA or with DNA encoding a model tumor antigen and a cytokine. Gene Ther. 7:1137-1147.
49. Shalaby, K. A., L. Yin, A. Thakur, L. Christen, E. G. Niles, and P. T. LoVerde. 2003. Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes. Vaccine 22:130-136.
50. Sher, A., D. Fiorentino, P. Caspar, E. Pearce, and T. Mosmann. 1991. Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. J. Immunol. 147:2713-2716.
51. Smithers, S. R., and M. J. Doenhoff. 1982. Schistosomiasis. Immunology of parasitic diseases, no. 527 Coordinating ed., S. Cohen and K. S. Warren. Blackwell Scientific Publications, Oxford, United Kingdom.
52. Smithers, S. R., and R. J. Terry. 1969. Immunity in schistosomiasis. Ann. N. Y. Acad. Sci. 160:826-840.
53. Stewart, C. C., and S. J. Stewart. 1999. Four color compensation. Cytometry 38:161-175.
54. Stewart, C. C., and S. J. Stewart. 2001. Multiparameter data acquisition and analysis of leukocytes by flow cytometry. Methods Cell Biol. 64:289-312.
55. Todd, C. W., and D. G. Colley. 2002. Practical and ethical issues in the development of a vaccine against Schistosomiasis mansoni. Am. J. Trop. Med. Hyg. 66:348-358.
56. Waine, G. J. 1994. Nucleic acid vaccines. Parasitol. Today 10:453-454.
57. Wynn, T. A., and K. F. Hoffmann. 2000. Defining a schistosomiasis vaccination strategy-is it really Th1 versus Th2? Parasitol. Today 16:497-501.